The AJCC provides individuals and member organizations the opportunity to join both the Executive and Full Committees in order to work with other medical professionals to advance the mission of the AJCC.


The AJCC Executive Committee is the decision-making body of our organization and sets the strategic direction. The Committee is comprised of representatives from our Sponsoring Member Organizations and Standing Committee Chairs. With varied backgrounds, each individual adds a unique, multidisciplinary perspective to the organization, while sharing a common commitment to produce validated systems for the classification and management of cancer, including state -of-the-science prognostic tools and resources.


David R. Byrd, MD, FACS, AJCC Chair

Dr. Byrd has served as the AJCC Vice-Chair since 2008. Dr. Byrd was installed as the AJCC Chair at the conclusion of the 2013 Annual Meeting. He is an editor of the 8th Edition and past member of the editorial board for the 2nd Edition AJCC Cancer Staging Atlas and the 7th Edition AJCC Cancer Staging Manual. Dr. Byrd is a University of Washington professor of surgery, the section chief of surgical oncology and the director of the Melanoma Center. His clinical interests are surgical oncology, endocrine neoplasms (thyroid, parathyroid, adrenal), gastrointestinal and pancreatic cancers, breast cancer, melanoma, molecular changes in pancreatic cancer and genetic and clinical studies on melanoma. His research interests are molecular changes in pancreatic cancer, genetic and clinical studies on melanoma, and lymphatic mapping in breast cancer and melanoma.


BrooklandCrop resize.jpgRobert K. Brookland, MD, FACR, FACRO, AJCC Vice-Chair

Dr. Brookland received his medical degree at Georgetown University School of Medicine. After a two year Internal Medicine residency, he went to the University of Pennsylvania where he served as Chief Resident and The American Cancer Society Fellow in Radiation Oncology. A board certified radiation oncologist, Dr. Brookland moved to Maryland in 1984. He is Chairman of the Department of Radiation Oncology at the Greater Baltimore Medical Center and has published papers in the area of cancers of the breast, cervix and kidney. In addition to his clinical practice, Dr. Brookland has been active in professional education, having served as Chairman of Professional Education for the American Cancer Society and Director of Continuing Medical Education at GBMC. He has been a member of the Medical Advisory Committee for the Governor’s Cancer Commission, Maryland Board of Physician Quality Assurance, Department of Health and Mental Hygiene and chaired the Peer Review Committee for the Baltimore County Medical Association where he currently serves as a member of the Board of Governors. D. Brookland served as Chairman of the Board for the American Cancer Society’s Maryland, Mid-Atlantic and South Atlantic Divisions, and is currently a member of its National Board of Directors.  He has been an active lobbyist in Annapolis, fighting for Tobacco Control legislation and mammography coverage by insurers. Dr. Brookland has been a guest lecturer at Towson State University, all of the area TV stations, cable programs including CNN, and many radio programs. He has been called upon for stories by the Baltimore Sun and Baltimore Magazine, who named him one of Baltimore’s Top Doctors. The Daily Record has named Dr. Brookland Health Care Hero Finalist for Advancement in Health Care and the Baltimore County Medical Association awarded Dr. Brookland with its Thomas E. Hobbins Distinguished Service Award. Dr. Brookland has received both the Mildred Mindell Cancer Foundation’s Humanitarian Award, as well as the St. George Medal, the highest national recognition by the American Cancer Society. He now serves as Chairman of The GBMC Foundation, which this year has raised over 11 million dollars for the philanthropic benefit of GBMC and the community.


Carolyn C. Compton, MD, PhD, FCAP, AJCC Immediate Past Chair

Dr. Compton is an academic pathologist specializing in gastrointestinal disease and is board certified in both anatomic and clinical pathology. She is a Professor at Arizona State University and an Adjunct Professor of Pathology at both the University of Arizona and Johns Hopkins. At ASU she is on the faculty of the College of Health Solutions and the School of the Science of Healthcare Delivery. She is the Chief Medical Officer of the National Biomarkers Development Alliance, a member of the Biodesign Institute and the Complex Adaptive Systems Initiative. She is a former Professor of Pathology at Harvard Medical School, Chief of Gastrointestinal Pathology at Massachusetts General Hospital and Pathologist-in-Chief of the Boston Shriners Children’s Hospital. More recently she has served as the CEO and President of the Critical Path Institute (2012), the Director of Biorespositories and Biospecimen Research at the National Cancer Institute (2005-2011), and the Strathcona Professor and Chair of the Department of Pathology at McGill University and Pathologist-in-Chief of the McGill University Health Center (2000-2005). She is the current Chair of the American Joint Committee on Cancer. She has authored more than 500 scientific manuscripts, review articles, books and chapters.


David P. Winchester, MD, FACS, AJCC Executive Director 
DP Winchester photo.png

Dr. Winchester graduated from Northwestern University and received his general surgical training at Northwestern.  He completed his surgical oncology fellowship at M.D. Anderson Cancer Center.  He is currently Clinical Professor of Surgery at the University of Chicago, Pritzker School of Medicine and the immediate past Chairman of the Department of Surgery of NorthShore University HealthSystem (formerly Evanston Northwestern Healthcare). He is the Medical Director of the National Cancer Programs of the American College of Surgeons and Principal Investigator of the National Cancer Database (NCDB) with a focus on tracking outcomes in cancer patients and promoting continuous quality improvement of cancer care.  Dr. Winchester has authored 200 peer-reviewed journal articles, serves on 10 editorial boards and has edited/co-edited 5 books.  He is a past-president of the Society of Surgical Oncology and currently serves as the Executive Director of the American Joint Committee on Cancer.  He is the past Chairman of the National Accreditation Program of Breast Centers (NAPBC) for the American College of Surgeons.  He is an honorary member of the American Society for Therapeutic Radiology and Oncology and an honorary fellow of the American College of Radiology.  He is the recipient of the first annual Society of Surgical Oncology Distinguished Service Award.


Mahul B. Amin, MD, FCAP, 8th Edition Editor-in-Chief

Dr. Amin is the Professor and Chairman, UTHSC Gerwin Chair for Cancer Research at the University of Tennessee Health Science Center. Dr. Amin earned his medical degree at G.S. Medical College and King Edward Memorial Hospital in Bombay, India. He is a national and international consultant in tumors of the genitourinary tract, including prostate, urinary bladder, kidney, and testis. Dr. Amin is a world-renowned expert and educator in genitourinary pathology having co-authored the current WHO classification systems for urothelial tumors and renal neoplasms. Dr. Amin’s scientific interests are in the discovery and validation of biomarkers in urologic malignancies for clinical personalized medicine. He was involved with the first major descriptions and studies of entities in genitourinary pathology including lymphoepithelioma-like carcinoma of the bladder, micropapillary carcinoma of the bladder, acquired cystic disease associated renal cell carcinoma, clear cell-papillary renal cell carcinoma, thyroid-like carcinoma of the kidney and tubulocystic carcinoma of the kidney.  As a translational researcher Dr. Amin has been funded by numerous NCI/NIH and Department of Defense grants for prostate cancer pathology and pathology translational core services with numerous collaborators. Dr. Amin has also co-authored 8 books, including two Armed Forces Institutes of Pathology (AFIP) fascicles and a monograph on Gleason grading of prostate cancer and has authored over 265 publications and 34 book chapters. Dr. Amin has given over 270 urologic and oncopathologic grand rounds, lectures and workshops in 19 countries. Dr. Amin has been a member of the faculty for courses for the American Urology Association (AUA), United States and Canadian Academy of Pathologists (since 1995) and College of American pathologists since 2003. Dr. Amin was on the Executive Committee of the American Joint Committee on Cancer (AJCC) (2003-2011), a member of the Genitourinary Cancer Staging Task Force, 7th Edition of AJCC staging, and lead coordinator of the prostate cancer staging system. Dr. Amin has just been nominated (2013) to be the Editor-in-Chief of the eighth edition of the AJCC staging manual. He has served as the Chair of the Cancer Committee of the College of American Pathologists for almost a decade leading the College’s efforts to standardize cancer surgical pathology reporting throughout the United States and Canada. Dr. Amin is the North American Representative to the International Society of Urologic Pathologists (ISUP) from 2012. He has been Fellowship Director of Urologic Pathology since 1997 and the Editor-in-Chief of Advances in Anatomic Pathology since the year 2000. In 2001, Dr. Amin was awarded the young investigator award of the Arthur Purdy Stout Society and more recently was the recipient of highly prestigious awards through the College of American Pathologists (CAP) including the 2010 CAP Foundation Lansky Award and the 2010 CAP Distinguished Service Award.


James Brierley, MB, FRCP, FRCR, FRCPC
, Education and Promotions Committee Chair

Dr. Brierley is Professor of Radiation Oncology at the University of Toronto, Princess Margaret Hospital. He obtained his medical degree from Westminster Medical School, University of London. He initially did postgraduate training in Internal Medicine before transferring to Clinical Oncology. After obtaining his FRCR in the UK he went to Princess Margaret Hospital, Toronto for a year fellowship and stayed. He is interested in cancer staging and cancer surveillance as well as in the management of gastrointestinal malignancy and thyroid malignancy. He has written extensively on Cancer Staging and is actively involved in ensuring staging data is collected and used on a population basis. He is Cancer Care Ontario (CCO) Stage Lead, Canadian Partnership Against Cancer: Chair National Staging Advisory Committee and Surveillance Lead. He is Co-Chair UICC TNM Prognostic Factors Core Group and Chair of the AJCC Education and Promotions Working Group.

Stephen B. Edge, MD, FACS, Past Chair and 7th Edition Editor-in-Chief

Dr. Edge is Vice-President for Healthcare Outcomes and Policy and Professor of Oncology at Roswell Park Cancer Institute in Buffalo, NY. He attended medical school at Case Western Reserve University and trained at the CWRU Integrated Surgery Program and at the Surgery Branch of the National Cancer Institute. Dr. Edge’s clinical focus is in breast cancer and his research agenda is community-wide evaluation and improvement in the quality of cancer care. He is the past Chair of the Commission on Cancer of the American College of Surgeons, and serves on the Boards of the American Society of Clinical Oncology and  the National Comprehensive Cancer Network. He also the past Chair of the AJCC and the Editor-in-Chief of the 7th Edition of the AJCC Cancer Staging Manual.


Ted Gansler Photo 2015Ted Gansler, MD, MPH, MBA. Representative of the American Cancer Society

Ted Gansler, MD, MPH, MBA is a Senior Consultant for Molecular Epidemiology and Health Services Research in the American Cancer Society’s Intramural Research Program, the Editor of one of the Society’s journals (Ca: A Cancer Journal for Clinicians), and the medical director of the Society’s Continuing Professional Education Program. Gansler previously led the development of the Society's Cancer Information Database, helping make its website and call center premier sources of cancer information for patients and the public. Before coming to the American Cancer Society in 1997, Dr. Gansler was an associate professor and director of the Cytopathology Division in the Department of Pathology and Laboratory Medicine at Emory University, where he currently serves as a clinical associate professor. Dr. Gansler received his bachelor's degree in zoology from Duke University, his MD from the University of Pittsburgh, his MBA from Georgia State University, and his MPH from Emory University's Rollins School of Public Health. He completed a residency in Anatomic and Clinical Pathology and a Cytopathology fellowship at the University of Pennsylvania. Dr. Gansler has represented the American Cancer Society on the AJCC Executive Committee since 2015.

Jeffrey E. Gershenwald, MD
, FACS, Informatics Committee Chair

Dr. Gershenwald is a Professor of Surgery in the Department of Surgical Oncology and a Professor in the Department of Cancer Biology at The University of Texas MD Anderson Cancer Center (MD Anderson) in Houston, Texas.  He is the Medical Director of the MD Anderson Melanoma and Skin Center, and co-leads the melanoma initiative for the Moon Shots program, also at MD Anderson. Dr. Gershenwald received his undergraduate degree from Cornell University and his M.D. from Cornell University Medical College. After completing his general surgery residency at The New York Hospital-Cornell Medical Center, Dr. Gershenwald completed a fellowship in Surgical Oncology at MD Anderson before joining the faculty there. In addition to his active surgical oncology practice that focuses on the care of patients with melanoma, Dr. Gershenwald holds numerous academic administrative appointments. Dr. Gershenwald serves as a member of the Executive Committee of the American Joint Committee on Cancer (AJCC), Chair of the AJCC Informatics Committee and Co-Chair of the AJCC melanoma staging committee that recently revised the melanoma staging system. He is a Co-Director of the NIH-funded Melanoma SPORE and Co-Director of the Melanoma Informatics, Tissue Resource, and Pathology Core, both at MD Anderson. Dr. Gershenwald’s research focuses on clinicopathological and molecular-based staging and prognostic assessment in melanoma and molecular mechanisms of melanoma progression. Dr. Gershenwald is a member of the Surgical Oncology Board of the American Board of Surgery and previously served as a member of the Executive Council and Chair of the Training Committee of the Society of Surgical Oncology. More recently, Dr. Gershenwald has been a founding member and Co-Chair of both the Melanoma Disease Working Group and Melanoma Analysis Working Group of The Cancer Genome Atlas (TCGA) project and MD Anderson lead for its melanoma TCGA tissue source site initiative.  He is also a member of the Melanoma Research Foundation Breakthrough Consortium Steering Committee, a member of the Stand Up 2 Cancer – Melanoma Research Alliance Joint Scientific Advisory Committee and a member of the Melanoma Research Alliance Medical Advisory Panel. Dr. Gershenwald has published more than 165 articles in peer-reviewed journals, as well as more than 100 editorials, abstracts, invited articles, and other publications. His many honors include the Physician-Scientist Program Award from MD Anderson, an American Cancer Society Research Scholar Grant Award to examine the “Biology and Significance of Melanoma Lymphatic Metastasis”, a Melanoma Research Alliance Team Science Award to study "Clinicopathological and Molecular Staging & Prognosis in Early-Stage Melanoma," and, for the past 11 years, Dr. Gershenwald has been listed in America’s Best Doctors.


Frederick L. Greene, MD, FACS, Emeritus

Dr. Greene received his medical school training at the University of Virginia and completed a residency in surgery at Yale University School of Medicine.  Dr. Greene was also an American Cancer Society Clinical Research Fellow at Yale.  Following residency, Dr. Greene served on active duty with the US Navy as surgeon aboard the USS Nimitz and at Portsmouth Naval Hospital. Dr. Greene was on the surgical faculty of the University of South Carolina from 1980 to 1997.  He served as Chairman of the Department of General Surgery and Surgical Residency Program Director at Carolinas Medical Center in Charlotte, NC from 1997 to 2012.  Dr. Greene is currently Clinical Professor of Surgery at the University of North Carolina School of Medicine.  Dr. Greene is an active clinician in the area of surgical oncology and has been involved in organizational work pertaining to cancer for a number of years.  He is a member of a number of editorial boards including the Journal of Clinical Oncology, Surgical Endoscopy, CA-A Cancer Journal for Clinicians and is Associate Editor of the Annals of Surgical Oncology. Dr. Greene has served on the Commission on Cancer of the American College of Surgeons and has served as the Chairman of the Commission. He has represented the American College of Surgeons on the American Joint Committee on Cancer (AJCC) and served as Chair of the AJCC from 2000-2004.  Dr. Greene represented the AJCC and has served as Vice-Chair of the TNM Staging Core Group of the International Union Against Cancer (UICC) based in Geneva, Switzerland. Dr. Greene is also Editor of the 6th and 7th Editions of the AJCC Cancer Staging Manual. Dr. Greene's publications have included approximately 150 papers, 30 book chapters, and two textbooks relating to cancer surgery and, specifically, the use of laparoscopic surgery in the management of cancer patients.  Dr. Greene is a Fellow of the American College of Surgeons and has served as a Governor and Vice-President. He belongs to numerous surgical organizations including the Society of Surgical Oncology, the Southern Surgical Association and the American Surgical Association. Dr. Greene is a Founding Member and was president of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) in 1992-93. He was awarded the Distinguished Service Award by SAGES in 2004. Dr. Greene was awarded the Jeffrey L. Ponsky Master Educator in Endoscopy Award by SAGES in 2012. 


Scott H. Kurtzman, MD, FACS, Finance Committee Chair

Dr. Kurtzman earned a B.A. in Neuroscience from Northwestern University, an MS from Roswell Park Memorial Institute, State University of New York and his M.D. from Albany Medical College of Union University. During his general surgery residency, Dr. Kurtzman was a Medical Staff Fellow, Surgery Branch, at the National Cancer Institute in Bethesda, Maryland. He completed his General Surgery Residency at the University of Medicine and Dentistry of New Jersey in Newark, New Jersey. He then completed a Surgical Oncology Fellowship in 1990 at Memorial Sloan Kettering Cancer Center in New York. Dr. Kurtzman holds an academic appointment as Professor of Surgery at the University of Connecticut Health Center in Farmington, Connecticut.  He is currently the Chairman of Surgery and Program Director of the General Surgery Residency Program at Waterbury Hospital, Waterbury CT. His clinical interests are in breast cancer, melanoma and sarcoma. He is the Governor at Large to the American College of Surgeons for Connecticut and represents the Society of Surgical Oncology to the National Accreditation Program for Breast Centers where he serves as the Chair of the Standards and Accreditation Committee and is a member of the Executive Committee. He represents the Dr. Kurtzman holds an academic appointment as Professor of Surgery at the University of Connecticut Health Center in Farmington, Connecticut.  He is currently the Chairman of Surgery and Program Director of the General Surgery Residency Program at Waterbury Hospital, Waterbury CT. His clinical interests are in breast cancer, melanoma and sarcoma. He is the Governor at Large to the American College of Surgeons for Connecticut and represents the Society of Surgical Oncology to the National Accreditation Program for Breast Centers where he serves as the Chair of the Standards and Accreditation Committee and is a member of the Executive Committee. He represents the American College of Surgeons on the AJCC.  He serves as Chair of the Finance Committee and is a member of Executive Committee, Informatics Committee, 8th Edition Working Group and Membership and Bylaws Committee. Dr. Kurtzman was a co-editor of the 2nd Edition of the Staging Atlas. Dr. Kurtzman has authored many peer-reviewed publications and numerous editorials, book chapters and other invited publications on cancer research and surgical oncology.


Alicia K. Morgans, MD, MPH, Representative of the American Society of Clinical OncologyMorgans-photo.jpg

Alicia Morgans, MD, MPH is an Associate Professor of Medicine in the Division of Hematology/Oncology at the Northwestern University Feinberg School of Medicine in Chicago, Illinois. She completed her MD and internal medicine residency at the University of Pennsylvania Perelman School of Medicine, and her fellowship at Dana Farber Cancer Institute/MGH Cancer Center. She is a clinician and physician investigator specializing is investigating complications of systemic therapy for prostate cancer survivors.  Her work has included the study of skeletal, cardiovascular, diabetic, and cognitive complications of prostate cancer survivorship, as well as treatment decision making in the metastatic prostate cancer population. In addition, she has been awarded several federal and foundation grants to investigate the cognitive effects of hormonal treatments in advanced prostate cancer, and treatment decisions in men with metastatic prostate cancer. She also has nationally recognized expertise in patient reported outcome and quality of life studies in men with advanced prostate cancer, and as well as incorporating patient preferences and beliefs into clinical decision making.  Dr. Morgans serves as the Principal Investigator for multiple therapeutic prostate cancer and bladder cancer clinical trials at NU.​

Moul-labcoat-300dpi 2010.jpgJudd W. Moul, MD, FACS, Membership and Bylaws Committee Chair

Dr. Moul is James H. Semans, MD Professor of Surgery, Division of Urologic Surgery and Duke Cancer Institute at Duke University Medical Center.  Prior to joining Duke, he was Professor of Surgery at the Uniformed Services University of the Health Sciences (USUHS) in Bethesda, Maryland and an attending Urologic Oncologist at the Walter Reed Army Medical Center (WRAMC) in Washington, DC. In addition, he was Director of the Center for Prostate Disease Research (CPDR); a Congress-mandated research program of the Department of Defense based at USUHS and WRAMC. In 2004, he completed a 26-year U.S. Army career, retiring as a full Colonel in the Medical Corps, and became Chief of the Division of Urologic Surgery at Duke. Serving as Chief from 2004 to 2011, he brought innovation and growth to the program. Most notably, he started the Duke Prostate Center, expanded the urology residency training program through a novel collaboration with the Department of Defense and was able to maintain Duke Urology as a top 10 program in the nation throughout his tenure. Dr. Moul completed his Urologic Oncology Fellowship at Duke University and graduated Summa Cum Laude from Pennsylvania State University. He earned his medical degree from Jefferson Medical College, where he was elected to Phi Beta Kappa and Alpha Omega Alpha. Dr. Moul currently serves on the editorial boards of Prostate Cancer, Prostate Cancer and Prostatic Diseases, BJU International, American Journal of Men’s Health, Brazilian Journal of Urology, World Journal of Urology and Oncology REALTIME. He has published over 500 medical and scientific manuscripts and book chapters and has lectured at national and international meetings. He has appeared on ABC, NBC, CNN, PBS, and other media as a prostate cancer authority. Honors and awards received have included the American Medical Association’s Young Physicians Section Community Service Award for his national involvement in prostate cancer patient support groups, the Sir Henry Welcome Research Medal and Prize from the Association of Military Surgeons of the United States, the prestigious Gold Cystoscope Award by the American Urological Association, the Baron Dominique Jean Larrey Military Surgeon Award for Excellence, the Order of Military Medical Merit from the Surgeon General at the US Army and the Castle Connolly National Physician of the Year award.


Olawaiye Crop resize.jpgAlexander B. Olawaiye, MD, MRCOG, FACOG, Education and Promotions Committee Vice-Chair

Dr. Olawaiye is a clinical and translational science investigator. He also does research in medical education. He has participated in multiple phase II and phase III clinical trials in gynecologic malignancies. Although his main focus is on endometrial cancer, his research interests also include ovarian, cervical and vulvar cancers. He is an active member of the Gynecologic Oncology Group (GOG) where he sits on the Committee for Experimental Medicine (CEM). He is also an active member of the Society for Gynecologic Oncology (SGO) where he sits on the Clinical Practice Committee (CPC). Dr. Olawaiye is the liaison representative of the SGO to the American Joint Committee for Cancer (AJCC). At the University of Pittsburgh, Dr. Olawaiye is a member of the Institutional Review Board (IRB) of the University of Pittsburgh and also a credentialing committee member for Magee Women’s Hospital of UPMC. He is the representative of the obstetrics and gynecology department to Technology and Innovative Practice Assessment Committee (TIPAC) of the University of Pittsburgh Medical Center. He is the Director for the Mercy Hospital Robotic surgery program and helps to oversee research for residents in both obstetrics & gynecology and also general surgery.

Daniel C. Sullivan, M.D., Representative of the American College of Radiology​Sullivan headshot.jpg

Dr. Sullivan is Professor Emeritus, Department of Radiology at Duke University Medical Center.  He completed radiology residency and nuclear medicine fellowship in 1977 at Yale-New Haven Hospital. From 1977 to 1997, Dr. Sullivan was in academic radiology, holding faculty appointments at Yale University Medical Center, Duke University Medical Center, and University of Pennsylvania Medical Center, before joining the National Cancer Institute at NIH in 1997. His areas of clinical and research expertise are in nuclear medicine and oncologic imaging, in particular focusing on improving the use of imaging as a biomarker in clinical trials.  From 1997 to 2007 Dr. Sullivan was Associate Director in the Division of Cancer Treatment and Diagnosis of the National Cancer Institute (NCI), and Head of the Cancer Imaging Program (CIP) at NCI.  During that time Dr. Sullivan and his staff developed many collaborative and multi-disciplinary programs to stimulate research in radiology departments.  In 2007 Dr. Sullivan returned to Duke Radiology as Vice Chair for Research.  In addition, he served as Science Adviser to the Radiological Society of North America (RSNA) from 2007 to 2015.  In his role with the RSNA Dr. Sullivan founded and chaired the Quantitative Imaging Biomarkers Alliance (QIBA) to define the field of quantitative imaging, including the evaluation and validation of imaging methods as biomarkers in clinical research ( Sullivan currently serves as QIBA Liaison for External Relations. Dr. Sullivan is a Fellow of the American College of Radiology, the Society for Breast Imaging, and the American Institute for Medical and Biological Engineering.  He was awarded the AUR Gold Medal in 2009.  Dr. Sullivan is a member of the National Advisory Council for Biomedical Imaging and Bioengineering (NIBIB) at NIH.  In 2013 Dr. Sullivan was named to the Editorial Board for the 8th Edition of Cancer Staging Manual, American Joint Committee on Cancer (AJCC).  In 2016 he became the American College of Radiology (ACR) representative to the AJCC and a member of the AJCC Executive Committee.

Mary Kay Washington, MD, PhD
, Representative of the College of American Pathologists

Dr. Washington is a surgical pathologist with interest in gastrointestinal and liver pathology. She graduated from the University of North Carolina at Chapel Hill School of Medicine and trained in anatomic and clinical pathology at Duke. Currently Dr. Washington is Professor of Pathology at Vanderbilt University Medical Center, where she is Director of GI and Liver Pathology. She has served on the Cancer Committee for the College of American Pathologists (CAP) for 8 years, and currently serves as committee chair and CAP liaison to the AJCC. She was an expert panel member for the Digestive Tumors Expert Panel for the 6th edition of the AJCC TNM Staging Manual and chaired the Foregut Task Force for the 7th edition.

David J. Winchester, MD, FACS, Representative of the American College of Surgeons

Dr. Winchester is Chief of the Division of Surgical Oncology at NorthShore University HealthSystem and a clinical professor of surgery of the University of Chicago Pritzker School of Medicine. Dr. Winchester serves on the Commission on Cancer and the American Joint Committee on Cancer. He is a member of the editorial board for Breast Diseases: A Year Book Quarterly and is an associate editor for the American Journal of Clinical Oncology. He has published widely on many breast cancer topics and served as editor of the two editions of the book Breast Cancer. Dr. Winchester is one of a handful of surgeons in the United States who performs nipple-sparing mastectomy for risk reduction and breast cancer. With this innovative procedure, an incision is made under the breast to help conceal scars, breast tissue is removed but the nipple and areola are preserved. During the same operation, a plastic surgeon restores the original contour of the breast or breasts. Dr. Winchester graduated with honors from Dartmouth College and earned his medical degree from Northwestern University. He completed his residency at Northwestern MemorialHospital and a surgical oncology fellowship at the University of Texas MD Anderson Cancer Center.

Vallerand Photo.JPGTheresa Vallerand, BGS, CTR

Theresa (Terry) Vallerand is a Certified Tumor Registrar with extensive experience in multiple levels of COC accredited hospitals from Community to Academic Programs as well as in public health as the quality manager for a state central registry.  Currently, Ms. Vallerand works as a manager in a health information management corporation. Ms. Vallerand has represented her industry as the National Cancer Registrars Association (NCRA) Liaison to the AJCC. She served on several expert panels and task forces for the AJCC Staging Manual, 8th Edition, providing cancer registry insight.  She has served in various leadership and volunteer positions with the NCRA as well as state and regional organizations.  She has been a speaker at both plenary and break-out sessions at NCRA Annual Conferences and has had multiple journal articles published.Ms. Vallerand is a graduate of the University of Maine and the Universit​y of Connecticut. Although a New Englander at heart, she has embraced Southern living after relocating to North Carolina.